Jupiter Endovascular Inc
Jupiter Endovascular Inc is a medical technology startup focused on developing innovative endovascular interventions through its proprietary Transforming Fixation (TFX) platform technology. The TFX-enabled procedures aim to provide enhanced stability, control, and anatomical protection for catheter-based therapies, initially targeting pulmonary embolism with plans to expand into other high-need cardiovascular applications. The company's technology allows for flexible navigation through the vasculature and precise stabilization at treatment sites, potentially expanding the capabilities of endovascular medicine.
Leadership & Board
- Current Number of Employees
- 59
- Current LinkedIn Followers
- 5,311
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $40M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $40M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Employee Trend
Jupiter Endovascular Inc had 59 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Jupiter Endovascular Inc had 5,311 followers as of October 12, 2026. The number of followers increased by 17 (0.32%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 08, 2025 | Series B | $40.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| LB Investment | Series B |
| Sonder Capital | Series B |
| Senvest Management | Series B |
Similar Companies
A snapshot of private companies similar to Jupiter Endovascular Inc, helping you discover and navigate related company profiles.
Related News and Analysis
